JAG2 and rectal cancer: Furthermore, TRF/mir-1280 inhibits the 3ʹ-UTR of JAG2, reduces JAG2 biosynthesis, inhibits the Notch pathway, and directly inhibits the migration and epithelial–mesenchymal transition (EMT) of rectal cancer cells [23, 62].